SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-037188
Filing Date
2019-10-21
Accepted
2019-10-21 08:20:09
Documents
5
Period of Report
2019-10-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tcon-8k_20191018.htm 8-K 53050
2 EX-4.1 tcon-ex41_8.htm EX-4.1 147991
3 EX-99.1 tcon-ex991_7.htm EX-99.1 301995
4 EX-99.2 tcon-ex992_6.htm EX-99.2 21574
5 GRAPHIC gulk3t4zcd2h000001.jpg GRAPHIC 12142
  Complete submission text file 0001564590-19-037188.txt   542890
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36818 | Film No.: 191158817
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences